Delayed Graft Function Prevention
Delayed Graft Function Prevention is a clinical strategy within induction immunosuppression that specifically aims to mitigate the risk of early post-transplant renal dysfunction by modulating immune responses and optimizing graft perfusion during the perioperative period.
288
Publications
12K
Citations
1.9K
Authors
578
Institutions
Publications per year
2017–2026
72
Parents
288
Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplantation
Daniel C. Brennan, John A. Daller, Kathleen D. Lake et al. · New England Journal of Medicine · 2006 · 730 citations · Full text
Medicine, Nephrology, Pharmacology +17
Machine Perfusion Versus Cold Storage for the Preservation of Kidneys Donated After Cardiac Death
Ina Jochmans, Cyril Moers, Jacqueline M. Smits et al. · Annals of Surgery · 2010 · 306 citations · Full text
Medicine, Nephrology, Surgery +17
1–5 of 288
1.9K
5
h-index
5
h-index
5
h-index
5
h-index
5
h-index
1–5 of 1.9K
578
Inserm
Paris, France
12 h-index
47 publications
3.8K citations
University of California, San Francisco
San Francisco, United States
10 h-index
22 publications
726 citations

Cedars-Sinai Medical Center
Los Angeles, United States
8 h-index
28 publications
3K citations
Université Paris Cité
Paris, France
7 h-index
20 publications
1.2K citations
Massachusetts General Hospital
Boston, United States
7 h-index
8 publications
670 citations

Johns Hopkins University
Baltimore, United States
6 h-index
22 publications
513 citations
University of Michigan
Ann Arbor, United States
6 h-index
23 publications
2.8K citations

University of Minnesota
Minneapolis, United States
6 h-index
24 publications
1.9K citations
1–8 of 578
37 publications · 2.1K citations
26
h-index
29 publications · 1.7K citations
23
h-index
59 publications · 1.4K citations
22
h-index
Repository · 30 publications · 939 citations
18
h-index
22 publications · 893 citations
17
h-index
1–5